Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial.
暂无分享，去创建一个
Jakob Nikolas Kather | M. Ebert | R. Hofheinz | A. Vogel | T. Zhan | R. Jakobs | T. Gaiser | E. Burgermeister | J. Betge | M. Karthaus | P. Thuss-Patience | Tobias Gutting | Philip Weidner | N. Haertel | M. Maenz | C. Bolling | N. Schulte | G. Stocker | S. Angermeier | Nadja M. Meindl-Beinker | M. de Wit | Tobias Leidig